Patient Management

2074 soru

Soru 41Soru →

A 42-year-old woman is evaluated in the clinic for fatigue and dyspnea on exertion. Laboratory testing reveals a microcytic anemia with a hemoglobin of 8.2 g/dL and a severely depressed serum ferritin. She is diagnosed with iron deficiency anemia secondary to heavy menstrual bleeding and is prescribed daily oral ferrous sulfate. To appropriately monitor the efficacy of her treatment, the physician considers the expected timeline of her hematologic recovery.

Arrange the following laboratory and clinical milestones in the chronological order they are expected to occur, from earliest (first) to latest (last), following the initiation of oral iron therapy.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence from earliest to latest is: Peak in the peripheral blood reticulocyte count -> Noticeable elevation in the hemoglobin concentration -> Complete normalization of the hemoglobin concentration -> Normalization of serum ferritin levels.
The physiological response to oral iron therapy follows a specific chronological sequence dictated by erythropoiesis and iron storage mechanisms. The bone marrow first responds by increasing red blood cell production, leading to a reticulocytosis that peaks at 7-10 days. This is followed by a gradual increase in hemoglobin, noticeable at 2-3 weeks, which eventually normalizes by 6-8 weeks. Finally, after the functional iron compartment (hemoglobin) is restored, excess iron is deposited in tissues, normalizing ferritin levels over 3-6 months.

Adım Adım Çözüm

1
Identify the earliest sign of bone marrow response to iron supplementation.
Peak in the peripheral blood reticulocyte count.
The bone marrow immediately utilizes the newly available iron for erythropoiesis, releasing immature red blood cells (reticulocytes) into the circulation. This peaks at 7 to 10 days.
2
Determine the timeline for initial improvement in the total red cell mass.
Noticeable elevation in the hemoglobin concentration.
As reticulocytes mature and more red blood cells are continuously produced, the hemoglobin level begins to rise measurably after 2 to 3 weeks.
3
Identify when the anemia is expected to be fully resolved.
Complete normalization of the hemoglobin concentration.
It takes approximately 6 to 8 weeks for sustained red blood cell production to fully correct the hemoglobin deficit and return it to the normal reference range.
4
Determine the final goal of monitoring therapy.
Normalization of serum ferritin levels.
Once the functional iron pool (hemoglobin) is restored, the body begins storing excess absorbed iron. Normalizing ferritin to replenish stores requires continuing iron therapy for 3 to 6 months after the anemia has resolved.

Anahtar Kavram

Timeline of hematologic response and iron store repletion when evaluating treatment efficacy for iron deficiency anemia.
Tahmini Süre:1m 0s
Soru 42Soru →

Emergency medical services bring a 72-year-old male resident of a skilled nursing facility to the acute care setting following a two-day history of worsening confusion, fever, and purulent sputum production. Upon triage, he appears lethargic and is in mild respiratory distress. Vital signs reveal a temperature of 38.9°C (102.0°F), a blood pressure of 88/56 mmHg, a heart rate of 112/min, and a respiratory rate of 26/min. Room air pulse oximetry indicates an oxygen saturation of 89%. Auscultation of the lungs demonstrates dense, coarse crackles localized to the right lower lung base. A portable chest radiograph confirms a new dense consolidation in the right lower lobe. A review of his electronic medical record reveals a prior ischemic stroke complicated by oropharyngeal dysphagia. Notably, he was discharged from the hospital one month ago after being treated for complicated pyelonephritis with a 10-day course of intravenous levofloxacin. Blood and sputum cultures are sent to the laboratory.

Which of the following antimicrobial agents should be included in his initial empiric pharmacologic regimen? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Vancomycin; Cefepime

Cevap

Vancomycin and cefepime
The correct combination includes vancomycin and cefepime. This patient presents with severe pneumonia and has specific risk factors for resistant pathogens, namely a recent hospitalization and receipt of intravenous antibiotics within the past 90 days. Therefore, empiric therapy must be broadened beyond standard community-acquired regimens to cover Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Vancomycin provides the necessary MRSA coverage, while cefepime serves as an appropriate anti-pseudomonal beta-lactam.

Adım Adım Çözüm

1
Assess the severity of the pneumonia and identify risk factors for resistant organisms.
The patient has severe pneumonia with risk factors for MRSA and Pseudomonas aeruginosa due to a recent hospitalization and receipt of intravenous antibiotics in the last 90 days.
Identifying risk factors for resistant pathogens dictates the need to broaden empiric antimicrobial coverage beyond standard community-acquired pneumonia regimens.
2
Select appropriate empiric antimicrobial agents based on the identified risk factors.
Select an anti-MRSA agent (vancomycin) and an anti-pseudomonal beta-lactam (cefepime).
Standard community-acquired regimens are insufficient for this patient; dual coverage targeting both MRSA and Pseudomonas is required to optimize survival.

Anahtar Kavram

Patients presenting with severe pneumonia who have specific risk factors (e.g., recent hospitalization and intravenous antibiotic use within the past 90 days) require empiric broad-spectrum coverage targeting both MRSA and Pseudomonas aeruginosa.
Soru 43Soru →

An internist is preparing hospital discharge orders for a 6969-year-old male who was admitted four days ago for an acute exacerbation of heart failure. The patient has a known history of ischemic cardiomyopathy with a left ventricular ejection fraction of 25%25\%, type 2 diabetes mellitus, and stage 3 chronic kidney disease. Following successful intravenous diuresis, he is now euvolemic and breathing comfortably on room air.

Vital signs today show a blood pressure of 118/74118/74 mmHg and a heart rate of 7272/min.

Current medications planned for discharge include:
- Lisinopril 2020 mg daily
- Carvedilol 12.512.5 mg twice daily
- Dapagliflozin 1010 mg daily
- Oral torsemide 2020 mg daily

Laboratory results obtained this morning:
TestResult
Sodium139139 mEq/L
Potassium4.34.3 mEq/L
Blood urea nitrogen2424 mg/dL
Creatinine1.61.6 mg/dL (baseline 1.51.5 mg/dL)

To fully optimize guideline-directed medical therapy, the internist plans to prescribe spironolactone before the patient leaves the hospital.

Which of the following is the most appropriate action or instruction regarding the addition of this medication?

Cevabı ve açıklamayı göster

Cevap: Initiate the medication and arrange for a follow-up basic metabolic panel in one to two weeks.

Cevap

The most appropriate action is to initiate the medication and arrange for a follow-up basic metabolic panel in one to two weeks.
The correct answer involves initiating the medication and scheduling a follow-up metabolic panel in one to two weeks. Mineralocorticoid receptor antagonists (MRAs) such as spironolactone provide a significant mortality benefit in patients with heart failure with reduced ejection fraction (HFrEF). However, because they are potassium-sparing diuretics, their use carries a substantial risk of hyperkalemia and worsening renal function. This risk is heavily amplified in patients with underlying chronic kidney disease and those concurrently taking ACE inhibitors (like lisinopril), ARBs, or ARNIs. Therefore, clinical guidelines strongly recommend checking serum potassium and renal function within 11 to 22 weeks after initiating an MRA or increasing its dose to prevent life-threatening hyperkalemia.

Adım Adım Çözüm

1
Identify the patient's underlying conditions and current status.
The patient has heart failure with reduced ejection fraction (HFrEF) and chronic kidney disease, and is currently euvolemic on a regimen of lisinopril, carvedilol, dapagliflozin, and torsemide.
Establishing the clinical baseline is necessary to determine what guideline-directed therapies are missing and what risks they may pose.
2
Evaluate the safety and indications for adding spironolactone.
Spironolactone is a mineralocorticoid receptor antagonist (MRA) indicated for HFrEF to reduce mortality. The patient's creatinine (1.61.6 mg/dL) and potassium (4.34.3 mEq/L) are within safe parameters for initiation.
MRAs are contraindicated in severe renal failure or baseline hyperkalemia, so lab values must be verified before prescribing.
3
Determine the necessary follow-up protocol for the new medication.
Guidelines mandate checking a basic metabolic panel within 11 to 22 weeks of starting an MRA.
The combination of an MRA, an ACE inhibitor (lisinopril), and baseline chronic kidney disease significantly elevates the risk of acute hyperkalemia and renal dysfunction, requiring prompt surveillance.

Anahtar Kavram

Initiation of mineralocorticoid receptor antagonists in heart failure requires close laboratory monitoring of potassium and renal function, typically within 1 to 2 weeks, due to the risk of hyperkalemia, especially when co-administered with ACE inhibitors.
Soru 44Soru →

A 68-year-old man is evaluated in the hospital on the third day of admission for community-acquired pneumonia. He was initially started on intravenous ceftriaxone and azithromycin. The patient reports feeling significantly better, with a marked decrease in his cough and complete resolution of his shortness of breath. He has been afebrile for the past 2424 hours and is tolerating a regular diet without difficulty.

Vital signs are:
Temperature: 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F})
Blood pressure: 126/78 mm Hg126/78\text{ mm Hg}
Heart rate: 78/min78/\text{min}
Respiratory rate: 14/min14/\text{min}
Oxygen saturation: 96%96\% on room air

Laboratory studies show a leukocyte count of 8,500/μL8,500/\mu\text{L}, which has decreased from 15,200/μL15,200/\mu\text{L} on admission. A chest radiograph obtained this morning demonstrates a persistent right lower lobe consolidation, which is unchanged compared to the admission radiograph.

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Transition to an oral antibiotic regimen and arrange for hospital discharge

Cevap

The most appropriate step is to transition the patient to an oral antibiotic regimen and arrange for hospital discharge.
The patient has community-acquired pneumonia and is demonstrating an excellent clinical response to empiric antibiotic therapy. He meets all standardized criteria for clinical stability: he is afebrile, hemodynamically stable, has a normal respiratory rate and oxygen saturation, and is able to maintain oral intake. Once clinical stability is achieved (usually within 48 to 72 hours), patients should be transitioned from intravenous to oral antibiotics and discharged home to complete their treatment course. The persistence of the lung consolidation on the repeat chest radiograph is a normal and expected finding. Radiographic resolution of pneumonia significantly lags behind clinical improvement and can take up to 6 to 12 weeks. Therefore, treatment de-escalation and hospital discharge should be guided entirely by clinical criteria rather than radiographic findings.

Adım Adım Çözüm

1
Evaluate the patient's clinical response to the current empiric antibiotic therapy.
The patient is afebrile, hemodynamically stable, breathing comfortably on room air, and tolerating an oral diet. This indicates excellent clinical stability and treatment success.
Determining clinical stability is the critical first step in deciding whether to de-escalate therapy or prepare for discharge.
2
Interpret the chest radiograph findings in the context of the patient's clinical improvement.
The persistent right lower lobe consolidation is an expected finding. Radiographic resolution of pneumonia lags behind clinical resolution by several weeks.
Misinterpreting a normal delay in radiographic clearing as treatment failure can lead to inappropriate and potentially harmful management decisions.
3
Determine the optimal management plan based on the assessment.
Transition to oral antibiotics and arrange for safe discharge home.
Once clinical stability is reached on intravenous antibiotics, promptly transitioning to oral therapy and discharging the patient minimizes hospital length of stay and reduces the risk of nosocomial complications.

Anahtar Kavram

In patients with community-acquired pneumonia, radiographic resolution significantly lags behind clinical improvement; discharge decisions should be based on clinical stability criteria, not on the clearance of infiltrates on a chest radiograph.
Tahmini Süre:1m 0s
Soru 45Soru →

A 52-year-old man comes to the clinic for an urgent evaluation due to new-onset hand tremors and worsening headaches over the past three days. He underwent a deceased-donor renal transplantation eight months ago for end-stage renal disease secondary to polycystic kidney disease. His maintenance immunosuppression regimen consists of tacrolimus, mycophenolate mofetil, and low-dose prednisone. Two weeks ago, he was seen at a local urgent care clinic for a sore throat and thick, white, scrapable plaques on his tongue and buccal mucosa. He was prescribed a 14-day course of an oral medication for this condition. Today, his temperature is 37.1°C (98.8°F), blood pressure is 158/92 mm Hg, and pulse is 88/min. Physical examination is notable for a fine resting tremor in both hands. Laboratory studies reveal a serum creatinine of 2.4 mg/dL, which is significantly elevated from his baseline of 1.3 mg/dL measured one month ago. Which of the following medications was most likely prescribed at the urgent care clinic?

Cevabı ve açıklamayı göster

Cevap: Fluconazole

Cevap

Fluconazole
The correct answer is the oral triazole antifungal, fluconazole. The patient's initial presentation of thick, white, scrapable plaques on the oral mucosa is diagnostic of oropharyngeal candidiasis (oral thrush), a common opportunistic infection in solid organ transplant recipients on maintenance immunosuppression. His current symptoms of acute kidney injury (elevated creatinine), new-onset tremors, headache, and hypertension are hallmark features of calcineurin inhibitor (tacrolimus) toxicity. Tacrolimus is primarily metabolized by the cytochrome P450 3A4 (CYP3A4) enzyme system. Fluconazole is a potent inhibitor of CYP3A4. When fluconazole is coadministered with tacrolimus, it significantly impairs tacrolimus clearance, leading to elevated systemic trough levels and subsequent nephrotoxicity and neurotoxicity. In clinical practice, if systemic azole therapy is required in a patient on a calcineurin inhibitor, empirical preemptive dose reduction of the calcineurin inhibitor and close therapeutic drug monitoring are mandatory.

Adım Adım Çözüm

1
Diagnose the antecedent condition described as thick, white, scrapable plaques on the oral mucosa.
The clinical description is highly specific for oropharyngeal candidiasis (oral thrush), an opportunistic fungal infection common in immunosuppressed patients.
Identifying the initial infection is necessary to determine which class of medication was prescribed at the urgent care clinic.
2
Identify the cause of the patient's current symptoms (tremors, headache, hypertension, and acute kidney injury).
The presentation is classic for calcineurin inhibitor (tacrolimus) toxicity.
Tacrolimus has a narrow therapeutic index; elevated serum levels cause prominent nephrotoxicity and neurotoxicity.
3
Determine which treatment for oral candidiasis precipitates tacrolimus toxicity.
Fluconazole.
Tacrolimus is extensively metabolized by the hepatic and intestinal cytochrome P450 3A4 (CYP3A4) system. Systemic azole antifungals, such as fluconazole, are potent inhibitors of CYP3A4, leading to decreased tacrolimus clearance and subsequent toxicity.

Anahtar Kavram

Pharmacokinetic interactions of CYP3A4 inhibitors with calcineurin inhibitors
Tahmini Süre:1m 15s
Soru 46Soru →

Paramedics bring a 58-year-old woman to the emergency department after her husband witnessed her suddenly collapse and begin shaking. Upon arrival in the resuscitation bay, she is actively experiencing a generalized tonic-clonic seizure. Her husband states the seizure activity has been continuous for approximately 15 minutes without any return to consciousness. She has no known past medical history and takes no daily medications. Vital signs show a blood pressure of 145/90 mmHg, heart rate of 118/min, and oxygen saturation of 94% on a non-rebreather mask. Intravenous access is rapidly established by the nursing staff, and a point-of-care blood glucose level is 102 mg/dL.

Arrange the following pharmacologic interventions in the correct sequential order for the management of this patient's condition, starting from the most immediate initial therapy to the final step for super-refractory disease.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Administer intravenous lorazepam, 2) Administer intravenous fosphenytoin, 3) Initiate a continuous intravenous propofol infusion, 4) Initiate a continuous intravenous pentobarbital infusion.
The management of status epilepticus follows a strict time-based protocol. The initial therapy phase (0-20 minutes) requires a rapid-acting benzodiazepine such as intravenous lorazepam. This is followed by the second therapy phase (20-40 minutes), which utilizes a non-benzodiazepine antiseizure medication such as fosphenytoin to achieve sustained control. If clinical or electrographic seizures continue, the patient enters refractory status epilepticus (40-60 minutes), necessitating intubation and continuous intravenous anesthetic infusions such as propofol. Finally, if seizures persist despite general anesthesia for 24 hours or more, it is termed super-refractory status epilepticus, and profound barbiturate coma with pentobarbital or thiopental is indicated as a last resort.

Adım Adım Çözüm

1
Identify the clinical emergency and the current duration of the event.
The patient is in generalized convulsive status epilepticus (continuous seizure >5 minutes, currently at 15 minutes).
Accurate diagnosis and timing dictate the specific phase of the treatment algorithm.
2
Select the first-line pharmacologic intervention.
Intravenous lorazepam is administered immediately.
Benzodiazepines are the most rapid and effective agents for acutely halting seizure activity in the initial phase (5-20 minutes).
3
Select the second-line pharmacologic intervention.
Intravenous fosphenytoin (or levetiracetam/valproic acid) is administered.
A long-acting non-benzodiazepine antiseizure medication must be given to prevent recurrence or to treat seizures that do not respond to the initial benzodiazepine (20-40 minute phase).
4
Determine the approach for refractory and super-refractory cases.
Propofol is used for refractory cases, followed by pentobarbital if super-refractory.
Anesthetic infusions like propofol or midazolam are used when standard agents fail. Pentobarbital induces a deep barbiturate coma and is strictly a last resort due to its severe hemodynamic side effects.

Anahtar Kavram

The stepwise, time-dependent pharmacologic management algorithm for generalized convulsive status epilepticus.
Soru 47Soru →

During morning rounds in the intensive care unit, the medical team evaluates a patient receiving treatment for an acute massive pulmonary embolism. The 58-year-old male, who has a documented history of advanced chronic kidney disease (stage G4), was started on a continuous intravenous unfractionated heparin infusion upon admission. Which of the following laboratory parameters must be routinely monitored to ensure the efficacy and safety of this specific anticoagulant therapy? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Activated partial thromboplastin time (aPTT); Platelet count

Cevap

The correct parameters to monitor are the Activated partial thromboplastin time (aPTT) and the Platelet count.
The correct answers identify the aPTT and platelet count as essential monitoring parameters. Unfractionated heparin primarily affects the intrinsic coagulation pathway, meaning its therapeutic efficacy must be titrated using the aPTT (or anti-factor Xa levels). Additionally, unfractionated heparin carries a significant risk of heparin-induced thrombocytopenia (HIT), necessitating serial monitoring of the platelet count to promptly identify sudden drops that indicate this dangerous immune-mediated reaction.

Adım Adım Çözüm

1
Identify the primary medication and its pharmacokinetic profile.
The patient is receiving a continuous intravenous infusion of unfractionated heparin.
Different anticoagulants target different parts of the coagulation cascade and have distinct clearance and adverse effect profiles.
2
Determine the necessary efficacy monitoring parameter for this specific drug.
Activated partial thromboplastin time (aPTT) is selected.
Unfractionated heparin inhibits factors IIa and Xa, affecting the intrinsic pathway, which is measured by aPTT to ensure the infusion dose is within the therapeutic window.
3
Determine the necessary safety monitoring parameter unique to this specific drug.
Platelet count is selected.
Unfractionated heparin carries a high risk of causing heparin-induced thrombocytopenia (HIT), requiring serial platelet count monitoring to detect potentially catastrophic immune-mediated drops in platelets.

Anahtar Kavram

Monitoring Unfractionated Heparin Therapy
Soru 48Soru →

A 7676-year-old woman comes to the outpatient clinic for a routine follow-up. Two weeks ago, she was diagnosed with major depressive disorder, and she is agreeable to starting pharmacotherapy today. A prescription for sertraline is initiated. Her medical history includes essential hypertension, hyperlipidemia, and osteoarthritis. Her daily medications include hydrochlorothiazide, lisinopril, atorvastatin, and as-needed acetaminophen. Her blood pressure is 135/82 mmHg135/82\text{ mmHg} and her heart rate is 74/min74\text{/min}. Physical examination is unremarkable. In addition to assessing her clinical response to the new medication, which of the following is the most appropriate monitoring plan for this patient?

Cevabı ve açıklamayı göster

Cevap: Measure serum sodium concentration in 22 to 44 weeks

Cevap

Measure serum sodium concentration in 2 to 4 weeks.
The correct action is to measure the serum sodium concentration. Elderly patients are at an increased risk of developing the syndrome of inappropriate antidiuretic hormone secretion (SIADH) when treated with selective serotonin reuptake inhibitors (SSRIs) such as sertraline. This risk is significantly magnified when the patient is concurrently taking a thiazide diuretic (e.g., hydrochlorothiazide), which independently depletes sodium. Current clinical guidelines recommend checking a basic metabolic panel for serum sodium levels 22 to 44 weeks after initiating an SSRI in older adults, particularly those with interacting medications or baseline risk factors.

Adım Adım Çözüm

1
Analyze the patient's demographic profile and current medication regimen.
The patient is a 7676-year-old woman taking a thiazide diuretic (hydrochlorothiazide) who is starting a selective serotonin reuptake inhibitor (SSRI).
Age and polypharmacy significantly increase the risk of specific adverse drug events.
2
Identify the primary pharmacological risks associated with the new medication (sertraline).
SSRIs are strongly associated with the development of the syndrome of inappropriate antidiuretic hormone secretion (SIADH).
SIADH leads to euvolemic hyponatremia, which can cause severe neurologic complications in the elderly.
3
Determine compounding synergistic risk factors.
The risk of SSRI-induced hyponatremia is magnified in advanced age and by the concurrent use of thiazide diuretics, which independently cause sodium depletion.
Recognizing overlapping medication toxicities dictates the required surveillance.
4
Select the appropriate guideline-concordant monitoring strategy.
Measure a basic metabolic panel (specifically serum sodium) 22 to 44 weeks after initiation of the SSRI.
Timely laboratory evaluation detects asymptomatic hyponatremia, allowing for early intervention before clinical deterioration occurs.

Anahtar Kavram

Elderly patients initiating SSRI therapy, particularly those concurrently using thiazide diuretics, are at high risk for developing hyponatremia secondary to SIADH and require serum sodium monitoring within 2 to 4 weeks.
Tahmini Süre:1m 0s
Soru 49Soru →

A 78-year-old female patient is evaluated during a routine ambulatory appointment at a geriatrics clinic. Her daughter, who provides collateral history, expresses concern regarding the patient's escalating confusion and recent onset of urinary dribbling over the past month. The patient's medical history includes major depressive disorder, essential hypertension, type 2 diabetes mellitus, and painful diabetic peripheral neuropathy. Her daily medication regimen consists of metformin, amlodipine, sertraline, amitriptyline (initiated four weeks ago for neuropathy), and over-the-counter diphenhydramine (taken nightly for insomnia).

Vital signs show a heart rate of 92/min. Blood pressure is 138/82 mm Hg while supine and 112/68 mm Hg upon standing. Physical examination is notable for dry oral mucous membranes, delayed capillary refill, and a mildly distended, palpable mass in the suprapubic region. A bedside ultrasound of the bladder demonstrates a postvoid residual volume of 550 mL.

Which of the following is the most appropriate initial pharmacologic intervention?

Cevabı ve açıklamayı göster

Cevap: Discontinue amitriptyline and diphenhydramine

Cevap

Discontinue amitriptyline and diphenhydramine
The correct answer involves discontinuing both amitriptyline and diphenhydramine. This patient is exhibiting a classic anticholinergic toxidrome (manifesting as confusion, dry mucous membranes, and urinary retention leading to overflow incontinence) caused by the synergistic effects of a tricyclic antidepressant (amitriptyline) and a first-generation antihistamine (diphenhydramine). Elderly patients are particularly susceptible to the cumulative anticholinergic burden of multiple medications due to decreased hepatic and renal clearance, as well as age-related changes in the central nervous system. Additionally, her significant orthostatic hypotension is a direct result of the alpha-1 adrenergic receptor blockade characteristic of tricyclic antidepressants. The most appropriate initial intervention is deprescribing these offending agents to reverse the toxicity.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient presents with confusion, overflow urinary incontinence (postvoid residual 550 mL), dry mucous membranes, and severe orthostatic hypotension.
Synthesizing the physical findings and history is necessary to identify the underlying toxidrome.
2
Correlate the symptoms with the patient's medication list.
Amitriptyline and diphenhydramine are identified as medications with strong anticholinergic properties; amitriptyline additionally exerts significant alpha-1 adrenergic blocking effects.
Identifying the offending agents causing the adverse drug events is critical in the elderly, who are highly susceptible to polypharmacy cascades.
3
Determine the most appropriate clinical action.
The best intervention is to immediately discontinue the anticholinergic medications.
Reversing the toxidrome by removing the offending agents is the primary treatment before considering any alternative diagnostic or therapeutic pathways.

Anahtar Kavram

Cumulative anticholinergic burden in the elderly can present with delirium, overflow urinary incontinence, and dry mucous membranes, necessitating the prompt discontinuation of offending agents.

Alternatif Yöntem

A formal medication reconciliation utilizing the Beers Criteria or calculating the patient's Anticholinergic Cognitive Burden (ACB) score can systematically highlight the urgent need to deprescribe high-risk medications like amitriptyline and diphenhydramine.
Tahmini Süre:1m 15s
Soru 50Soru →

A 2222-year-old man with type 1 diabetes mellitus is being treated in the intensive care unit for diabetic ketoacidosis. He has been receiving a continuous intravenous regular insulin infusion, intravenous fluids, and potassium replacement for the past 1414 hours. Current laboratory evaluation reveals a blood glucose of 178178 mg/dL, a serum bicarbonate of 2020 mEq/L, and a calculated anion gap of 99 mEq/L. The patient is awake, alert, and reports feeling hungry. The physician decides to transition the patient to a subcutaneous insulin regimen. Arrange the following management and monitoring steps in the correct chronological sequence to safely accomplish this therapeutic de-escalation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with verifying diabetic ketoacidosis resolution, followed by administering subcutaneous basal insulin, maintaining an overlap with the intravenous insulin for 11 to 22 hours, discontinuing the intravenous infusion, and finally initiating routine preprandial monitoring.
The successful treatment of diabetic ketoacidosis requires a carefully monitored transition from continuous intravenous insulin to intermittent subcutaneous insulin. The protocol dictates that the physician must first confirm resolution of the ketoacidosis (anion gap ≤12\leq 12 mEq/L) and ensure the patient can tolerate oral intake. Because intravenous insulin clears the body within minutes and subcutaneous insulin takes 11 to 22 hours to begin working, subcutaneous basal insulin must be administered while the intravenous infusion is still running. This 11 to 22 hour overlap is critical to prevent a gap in insulin coverage, which would cause rapid rebound ketoacidosis. Only after this overlap period is complete should the intravenous infusion be discontinued. Finally, the patient is transitioned to routine maintenance monitoring, typically involving blood glucose checks before meals and at bedtime.

Adım Adım Çözüm

1
Assess clinical and laboratory criteria for diabetic ketoacidosis resolution.
The anion gap is closed (99 mEq/L) and the patient is able to eat.
Ensures that transitioning off continuous insulin is safe and physiologically appropriate.
2
Administer subcutaneous long-acting basal insulin.
A long-acting insulin depot is established in the subcutaneous tissue.
Provides baseline insulin coverage to prevent rebound hyperglycemia.
3
Overlap the intravenous and subcutaneous insulin for 11 to 22 hours.
Continuous insulin coverage is maintained during subcutaneous absorption.
Subcutaneous insulin takes time to reach systemic circulation and take effect.
4
Stop the continuous intravenous regular insulin infusion.
The patient is completely transitioned to subcutaneous insulin.
Intravenous insulin is no longer needed once the subcutaneous depot is active.
5
Transition to standard inpatient glycemic monitoring.
Blood glucose is checked before meals and at bedtime.
Allows for ongoing monitoring and administration of short-acting nutritional/correctional insulin.

Anahtar Kavram

Therapeutic De-escalation Protocol for Diabetic Ketoacidosis
Soru 51Soru →

A 58-year-old man is brought to the emergency department by his wife due to fever, severe headache, and confusion that started 12 hours ago. He has a past medical history of alcohol use disorder, type 2 diabetes mellitus, and hypertension. His temperature is 39.2°C (102.6°F), blood pressure is 110/70 mmHg, and heart rate is 115/min. On physical examination, he is lethargic but arousable. There is significant resistance to passive neck flexion. Funduscopic examination shows no papilledema. Lumbar puncture is performed, and cerebrospinal fluid (CSF) analysis reveals a leukocyte count of 2,400/mm³ (90% neutrophils), a glucose level of 30 mg/dL, and a protein level of 150 mg/dL. Gram stain of the CSF is pending.

Which of the following pharmacologic agents should be included in his immediate empiric regimen? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Ampicillin; Ceftriaxone; Vancomycin

Cevap

The immediate empiric regimen should include ampicillin, ceftriaxone, and vancomycin.
The patient's clinical presentation and cerebrospinal fluid analysis are consistent with acute bacterial meningitis. In adults aged 2 to 50 years, the most common pathogens are Streptococcus pneumoniae and Neisseria meningitidis, and standard empiric therapy includes vancomycin and a third-generation cephalosporin (e.g., ceftriaxone). However, in patients older than 50 years, or those with altered cellular immunity (such as from alcohol use disorder or diabetes), there is an increased risk of infection with Listeria monocytogenes. Therefore, ampicillin must be added to the empiric regimen. The correct multi-drug regimen includes vancomycin, ceftriaxone, and ampicillin.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and cerebrospinal fluid (CSF) findings.
The combination of fever, headache, nuchal rigidity, altered mental status, and a CSF profile with high neutrophils, low glucose, and high protein indicates acute bacterial meningitis.
Establishing the correct diagnosis dictates the choice of empiric antimicrobial therapy.
2
Identify the patient's demographic and medical risk factors.
The patient is over 50 years old (58 years) and has a history of alcohol use disorder and diabetes mellitus.
Age and comorbidities determine the likely causative organisms and the need for expanded antibiotic coverage.
3
Select the appropriate empiric antibiotic regimen based on the identified risk factors.
Vancomycin and ceftriaxone are selected for baseline coverage, while ampicillin is added specifically to cover Listeria monocytogenes.
Standard empiric therapy for adults includes vancomycin and a third-generation cephalosporin. Ampicillin must be added for patients >50 years or those who are immunocompromised.

Anahtar Kavram

Empiric antibiotic therapy for bacterial meningitis in adults >50 years or with immunocompromising conditions (such as alcoholism) requires a combination of vancomycin, a third-generation cephalosporin (e.g., ceftriaxone), and ampicillin.
Soru 52Soru →

A 6767-year-old male presents to the primary care clinic for a routine follow-up. Five years ago, he underwent a mechanical mitral valve replacement and has been maintained on chronic warfarin therapy. His target international normalized ratio (INR) is between 2.52.5 and 3.53.5. Over the past year, his laboratory values have been stable on a daily warfarin dose of 55 mg. Six days ago, he was evaluated at an urgent care facility for a suspected urinary tract infection and was prescribed a 77-day course of trimethoprim-sulfamethoxazole. The patient reports feeling well today. He denies any epistaxis, hematuria, melena, or easy bruising. Vital signs are within normal limits. Physical examination reveals clear lungs, normal heart sounds with a distinct mechanical click, and no petechiae or ecchymoses. His neurologic examination is unremarkable. A point-of-care INR obtained in the clinic today is 7.47.4. Which of the following is the most appropriate next step in management of this patient?

Cevabı ve açıklamayı göster

Cevap: Withhold the next one to two doses of warfarin and recheck the laboratory values in 2424 to 4848 hours

Cevap

Withhold the next one to two doses of warfarin and recheck the laboratory values in 2424 to 4848 hours.
This patient has a supratherapeutic INR of 7.47.4 but remains completely asymptomatic without any signs of clinical bleeding. The acute elevation is due to the recent initiation of trimethoprim-sulfamethoxazole, a strong inhibitor of CYP2C9 that decreases the metabolism of S-warfarin. According to standard clinical guidelines, for patients with an INR between 4.54.5 and 10.010.0 and no evidence of bleeding, the recommended management is to simply withhold the next 11 to 22 doses of warfarin, monitor the INR closely, and restart therapy at an appropriately adjusted (lower) dose once the INR returns to the therapeutic range. Routine use of oral vitamin K is not recommended in this specific range due to the risk of overcorrection and subsequent warfarin resistance.

Adım Adım Çözüm

1
Assess the patient's clinical stability and bleeding status.
The patient is completely asymptomatic with no signs of active bleeding or trauma on physical examination.
The presence or absence of major bleeding dictates whether rapid pharmacological reversal is required versus simple dose adjustment.
2
Evaluate the laboratory finding in the context of recent medication changes.
The INR is supratherapeutic at 7.47.4, likely driven by the recent addition of trimethoprim-sulfamethoxazole.
Trimethoprim-sulfamethoxazole inhibits CYP2C9, significantly decreasing warfarin clearance and abruptly increasing the INR.
3
Apply clinical guidelines for warfarin management based on the INR value.
For an INR between 4.54.5 and 10.010.0 without bleeding, guidelines recommend withholding 11 to 22 doses of warfarin and rechecking the INR.
Routine use of vitamin K in this range is advised against because it can cause warfarin resistance once the patient needs to resume anticoagulation.

Anahtar Kavram

Management of supratherapeutic INR without bleeding
Soru 53Soru →

A 42-year-old woman with a history of bipolar I disorder is admitted to the inpatient psychiatric unit with an acute manic episode. She has previously been nonadherent to medications but now agrees to initiate treatment with lithium carbonate. She has no other medical conditions and takes no other medications. Her physical examination is unremarkable. In addition to monitoring serum drug concentrations, which of the following laboratory parameters are necessary to evaluate at baseline and periodically during long-term maintenance therapy with this medication? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Thyroid-stimulating hormone (TSH); Serum calcium; Serum creatinine

Cevap

The correct parameters to monitor are thyroid-stimulating hormone (TSH), serum calcium, and serum creatinine.
Lithium is a mood stabilizer with well-known long-term toxicities affecting the kidneys (nephrogenic diabetes insipidus, chronic tubulointerstitial nephropathy), the thyroid gland (hypothyroidism, goiter), and the parathyroid glands (hyperparathyroidism). Therefore, standard of care dictates that baseline and periodic monitoring include serum creatinine, thyroid-stimulating hormone (TSH), and serum calcium. This ensures early detection and management of these adverse effects.

Adım Adım Çözüm

1
Identify the initiated medication and its pharmacologic profile.
The patient is starting lithium carbonate for bipolar disorder.
Different mood stabilizers have distinct adverse effect profiles requiring specific monitoring strategies.
2
Determine the known long-term adverse effects of lithium.
Lithium is associated with thyroid dysfunction, renal impairment, and hyperparathyroidism.
Baseline and ongoing surveillance must target the organ systems susceptible to toxicity.
3
Select the corresponding laboratory tests.
TSH (thyroid), serum creatinine (kidneys), and serum calcium (parathyroid) are the necessary tests.
These tests detect the most common and clinically significant end-organ complications of lithium therapy.

Anahtar Kavram

Baseline and ongoing monitoring for lithium therapy must include renal function (creatinine), thyroid function (TSH), and serum calcium due to the long-term risks of chronic kidney disease, hypothyroidism, and hyperparathyroidism.
Tahmini Süre:1m 30s
Soru 54Soru →

A 48-year-old man presents to the emergency department with an 8-hour history of severe, unremitting epigastric pain that radiates to his mid-back. He reports that the pain is exacerbated by lying supine and is partially relieved by leaning forward. He has had two episodes of non-bloody, non-bilious emesis since the pain began. His medical history is notable for hypertension treated with amlodipine. He does not use tobacco but drinks 3-4 alcoholic beverages daily. His temperature is 37.8∘C37.8^\circ\text{C} (100∘F100^\circ\text{F}), blood pressure is 138/86 mmHg138/86\text{ mmHg}, pulse is 105/min105/\text{min}, and respiratory rate is 18/min18/\text{min}. Physical examination shows a distressed patient with marked epigastric tenderness to palpation, but no rebound tenderness or guarding. Bowel sounds are hypoactive. Which of the following diagnostic tests should be included in the initial diagnostic workup of this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Serum lipase measurement; Right upper quadrant abdominal ultrasound

Cevap

The most appropriate initial diagnostic tests for this patient are serum lipase measurement and a right upper quadrant abdominal ultrasound.
The patient's presentation is highly suspicious for acute pancreatitis. The diagnosis of acute pancreatitis is established by the presence of at least two of three criteria: 1) characteristic acute-onset epigastric pain radiating to the back, 2) serum lipase elevation at least three times the upper limit of normal, and 3) characteristic findings on cross-sectional imaging (CT or MRI). Therefore, measuring serum lipase is an essential, non-invasive first step to confirm the diagnosis. Furthermore, because gallstones are the most common cause of acute pancreatitis, a right upper quadrant abdominal ultrasound is universally recommended as part of the initial evaluation in all patients to assess for cholelithiasis or biliary duct dilation.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient has acute-onset, severe epigastric pain radiating to the back, exacerbated by lying flat, along with a history of alcohol use. This is the classic presentation of acute pancreatitis.
Identifying the primary differential diagnosis dictates the required diagnostic criteria.
2
Determine the diagnostic criteria for acute pancreatitis.
Diagnosis requires two of the three following criteria: characteristic abdominal pain, serum lipase elevation (at least 3 times the upper limit of normal), and characteristic findings on cross-sectional imaging.
Guidelines specify that laboratory evaluation is the primary initial adjunct to the clinical history.
3
Select the appropriate initial laboratory and imaging tests.
Serum lipase must be drawn to fulfill diagnostic criteria. Concurrently, right upper quadrant ultrasound must be ordered to evaluate for gallstones, which are the most common cause of acute pancreatitis worldwide.
Initial tests should be highly sensitive, cost-effective, and non-invasive before progressing to advanced imaging or invasive procedures.

Anahtar Kavram

The initial diagnostic workup for suspected acute pancreatitis requires measuring serum lipase to confirm the diagnosis and performing a right upper quadrant abdominal ultrasound to assess for a biliary etiology.
Soru 55Soru →

A 48-year-old woman presents to the emergency department reporting a temperature of 38.4°C (101.1°F) measured at home. She is currently undergoing adjuvant chemotherapy with docetaxel and cyclophosphamide for stage II breast cancer; her last cycle was 10 days ago. She reports mild fatigue but denies chills, cough, dyspnea, abdominal pain, or dysuria. She lives with her husband 15 minutes away from the hospital and has been independently performing all daily activities.

Vital signs on arrival show a blood pressure of 122/78 mmHg, pulse of 88/min, respiratory rate of 14/min, and oxygen saturation of 99% on room air. Physical examination reveals a well-appearing, well-hydrated woman with no focal source of infection. An implanted venous port site shows no erythema or tenderness.

Laboratory studies reveal:
Hemoglobin: 10.5 g/dL
Leukocytes: 800/mm³
Absolute neutrophil count (ANC): 300/mm³
Platelets: 120,000/mm³
Comprehensive metabolic panel: within normal limits

Blood and urine cultures are obtained, and she is promptly given a dose of intravenous cefepime. After 4 hours of observation in the emergency department, she remains afebrile and hemodynamically stable, and she tolerates oral fluids without difficulty. Based on this patient's clinical risk profile and treatment response, which of the following is the most appropriate disposition?

Cevabı ve açıklamayı göster

Cevap: Discharge home with a prescription for oral ciprofloxacin and amoxicillin-clavulanate.

Cevap

Discharge home with a prescription for oral ciprofloxacin and amoxicillin-clavulanate.
The correct disposition for this patient is discharge home with a prescription for oral ciprofloxacin and amoxicillin-clavulanate. This patient has febrile neutropenia, which requires immediate empiric antibiotics. However, she meets the criteria for a low-risk presentation based on objective scoring systems such as the MASCC risk index (score ≥ 21). She is hemodynamically stable, lacks significant comorbidities (like COPD or hypotension), has a solid tumor rather than a hematologic malignancy, is younger than 60, and is experiencing only mild symptoms. Furthermore, she tolerates oral intake, is functionally independent, and has a reliable caregiver living in close proximity to the hospital. Clinical guidelines recommend that such low-risk patients receive an initial prompt dose of intravenous antibiotics in the emergency department, followed by discharge home with broad-spectrum oral antibiotics (usually a fluoroquinolone combined with amoxicillin-clavulanate) and close outpatient follow-up.

Adım Adım Çözüm

1
Identify the primary clinical problem and emergency.
The patient has chemotherapy-induced febrile neutropenia (fever >38.3°C and ANC <500/mm³).
Recognizing the syndrome is required to initiate the appropriate evidence-based clinical pathway.
2
Risk-stratify the patient using an objective severity score.
Calculate the Multinational Association for Supportive Care in Cancer (MASCC) risk index or use Clinical Index of Stable Febrile Neutropenia (CISNE) criteria.
Risk stratification determines whether the patient requires inpatient intravenous therapy or can be managed as an outpatient.
3
Evaluate the objective criteria and functional capacity.
The patient is young (<60), hemodynamically stable, has a solid tumor, no major medical comorbidities, mild symptoms, tolerates oral intake, and has excellent social support (lives with husband near the hospital). She scores >=21 on the MASCC index, placing her in the low-risk category.
Only low-risk patients with intact functional capacity and social support are candidates for outpatient disposition.
4
Determine the optimal disposition setting.
The patient is safely discharged home on empiric oral antibiotics (typically a fluoroquinolone plus amoxicillin-clavulanate) after initial assessment and IV antibiotic dosing in the ED.
This avoids unnecessary hospitalization and minimizes the risk of nosocomial infections while providing definitive care.

Anahtar Kavram

Low-risk febrile neutropenia patients (e.g., MASCC score >=21, hemodynamically stable, no organ dysfunction, tolerating oral intake, reliable social support) should be discharged home on empiric oral broad-spectrum antibiotics rather than being admitted for inpatient intravenous therapy.
Soru 56Soru →

A 68-year-old man is evaluated in the urgent care clinic for a 24-hour history of severe, progressive pain and swelling in his right knee. He is unable to bear weight on the affected leg. His medical history is significant for type 2 diabetes mellitus, hypertension, and stage 4 chronic kidney disease with a baseline estimated glomerular filtration rate (eGFR) of 24 mL/min/1.73 m224 \text{ mL/min/1.73 m}^2. Current medications include amlodipine, insulin detemir, and calcium acetate. Vital signs are temperature 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), pulse 88/min, and blood pressure 138/84 mm Hg. Physical examination reveals a swollen, erythematous, and exquisitely tender right knee with a moderate effusion. Arthrocentesis is performed. Synovial fluid analysis reveals a leukocyte count of 28,000/μL28,000/\mu\text{L} (85% neutrophils) and the presence of negatively birefringent, needle-shaped crystals under polarized light microscopy. Gram stain is negative. Which of the following is the most appropriate pharmacologic intervention for this patient's acute joint condition?

Cevabı ve açıklamayı göster

Cevap: Intra-articular triamcinolone

Cevap

Intra-articular triamcinolone is the most appropriate treatment.
Intra-articular triamcinolone is the most appropriate intervention because this patient has an acute monoarticular gout flare combined with severe chronic kidney disease (CKD stage 4). While NSAIDs, colchicine, and systemic/intra-articular glucocorticoids are all first-line options for acute gout in healthy individuals, patient comorbidities dictate the final choice. In severe renal impairment (eGFR <30 mL/min/1.73 m^2), NSAIDs are absolutely contraindicated due to the risk of precipitating acute-on-chronic renal failure. Colchicine should also be avoided due to the high risk of fatal toxicity. For a single accessible inflamed joint, intra-articular glucocorticoids provide rapid, targeted relief with minimal systemic absorption.

Adım Adım Çözüm

1
Interpret the synovial fluid analysis results.
The presence of negatively birefringent, needle-shaped crystals confirms the diagnosis of acute gouty arthritis. The elevated leukocyte count of 28,000/μL is an expected inflammatory response to the crystals.
Establishing a definitive crystal diagnosis eliminates the immediate need for empiric antibiotics despite the highly inflammatory fluid.
2
Review the patient's medical history for contraindications to standard therapies.
The patient has stage 4 chronic kidney disease (eGFR 24 mL/min/1.73 m^2).
Comorbidities dictate the safety profile of acute gout therapies. Standard first-line agents (NSAIDs and colchicine) rely on renal clearance or can directly damage the kidneys.
3
Select the optimal pharmacologic intervention based on the clinical presentation and safety profile.
Intra-articular triamcinolone is selected.
Because the patient has a monoarticular flare (one accessible joint) and severe renal impairment, a local glucocorticoid injection provides excellent efficacy while avoiding the systemic nephrotoxicity of NSAIDs and the systemic neuromyopathy risk of colchicine.

Anahtar Kavram

In patients with acute monoarticular gout and severe chronic kidney disease (eGFR < 30 mL/min/1.73 m^2), NSAIDs and colchicine are contraindicated; intra-articular glucocorticoids are the preferred first-line therapy.
Soru 57Soru →

A 22-year-old male university student is transported to the emergency department after falling approximately 3 meters (10 feet) from a balcony and striking his head on concrete. Emergency medical services report that he was initially conversant at the scene but became increasingly somnolent during transit. Upon arrival, he does not open his eyes to pain, makes no verbal sounds, and withdraws his left arm from painful stimuli. Vital signs demonstrate a blood pressure of 185/105 mmHg, a heart rate of 48/min, and a respiratory rate of 8/min with irregular breathing patterns. Physical examination reveals a right pupil that is 7 mm and unresponsive to light, while the left pupil is 3 mm and briskly reactive. Which of the following is the most appropriate immediate next step in management?

Cevabı ve açıklamayı göster

Cevap: Secure the airway with orotracheal intubation

Cevap

Secure the airway with orotracheal intubation
The most appropriate immediate next step is securing the airway with orotracheal intubation. This patient presents with a severe traumatic brain injury following a 'lucid interval,' classically associated with an epidural hematoma. His Glasgow Coma Scale (GCS) score is 6 (Eyes: 1, Verbal: 1, Motor: 4), and he exhibits clear signs of uncal herniation (ipsilateral fixed and dilated pupil) along with Cushing's triad (hypertension, bradycardia, and irregular respirations). According to standard trauma resuscitation protocols (ATLS), airway maintenance with simultaneous cervical spine protection is the paramount initial step. Any patient with a GCS of 8 or less cannot reliably protect their airway and requires immediate endotracheal intubation to prevent hypoxia and hypercapnia, which would further exacerbate secondary brain injury.

Adım Adım Çözüm

1
Calculate the patient's Glasgow Coma Scale (GCS) score.
The GCS score is 6 (Eyes: 1, Verbal: 1, Motor: 4).
To objectively quantify the level of consciousness and determine the need for airway protection.
2
Analyze the vital signs and pupillary findings.
The patient exhibits Cushing's triad (hypertension, bradycardia, irregular respirations) and an ipsilateral blown pupil.
These findings indicate severely elevated intracranial pressure and impending uncal herniation.
3
Prioritize interventions based on Advanced Trauma Life Support (ATLS) protocols.
Airway protection is identified as the absolute first priority.
A patient with a GCS of 8 or less cannot reliably protect their airway, making intubation the paramount first step before any diagnostic testing or secondary interventions.

Anahtar Kavram

In patients with severe traumatic brain injury (GCS of 8 or less), securing a definitive airway is the absolute first priority in the primary survey, preceding diagnostic imaging or medical management of intracranial pressure.
Soru 58Soru →

A 54-year-old woman presents to the emergency department after recording a temperature of 38.5°C (101.3°F) at home two hours ago. She has a history of stage II right breast cancer and underwent a lumpectomy six weeks ago. She is currently receiving adjuvant chemotherapy, with her most recent cycle of docetaxel and cyclophosphamide administered 8 days ago. The patient reports mild fatigue but denies chills, cough, shortness of breath, dysuria, abdominal pain, or diarrhea. She has no other significant medical conditions. She lives 10 miles from the hospital with her husband, who drove her to the emergency department today.

Temperature is 38.3°C (100.9°F), blood pressure is 122/78 mm Hg, pulse is 92/min, and respiratory rate is 16/min. Pulse oximetry is 99% on room air. The patient appears comfortable and in no acute distress. The implanted central venous catheter site is clean without erythema, induration, or tenderness. Cardiopulmonary examination is normal. The abdomen is soft and non-tender.

Laboratory studies show:
Leukocyte count: 1,100/µL
Absolute neutrophil count: 350/µL
Hemoglobin: 11.2 g/dL
Platelets: 145,000/µL
Blood urea nitrogen: 14 mg/dL
Serum creatinine: 0.8 mg/dL
Hepatic function panel: Normal

Chest radiograph shows no infiltrates. Urinalysis is unremarkable. The patient is able to tolerate oral fluids in the emergency department without nausea.

Which of the following is the most appropriate disposition for this patient?

Cevabı ve açıklamayı göster

Cevap: Discharge to home with oral ciprofloxacin and amoxicillin-clavulanate

Cevap

Discharge to home with oral ciprofloxacin and amoxicillin-clavulanate
The correct disposition is to discharge the patient home with oral antibiotics. This patient presents with febrile neutropenia, defined as a single oral temperature of ≥\geq 38.3°C (101°F) and an absolute neutrophil count (ANC) <500< 500/µL. While febrile neutropenia is an oncologic emergency, not all patients require inpatient admission. Risk stratification using validated tools, such as the Multinational Association for Supportive Care in Cancer (MASCC) risk index or the Clinical Index of Stable Febrile Neutropenia (CISNE), helps determine the appropriate care setting. This patient is considered low-risk because she has no significant medical comorbidities, is hemodynamically stable, lacks focal signs of infection (e.g., pneumonia, port infection), is able to tolerate oral intake, and has reliable social support and transportation. According to current guidelines, low-risk patients can be safely discharged home with oral empiric antibiotics. The standard outpatient regimen is a fluoroquinolone (e.g., ciprofloxacin or levofloxacin) plus amoxicillin-clavulanate to provide necessary broad-spectrum coverage, crucially including coverage against Pseudomonas aeruginosa.

Adım Adım Çözüm

1
Diagnose the acute condition based on vital signs and laboratory results.
The patient has febrile neutropenia, defined by a temperature ≥\geq 38.3°C and an absolute neutrophil count (ANC) <500< 500/µL.
Identifying febrile neutropenia is critical as it is an oncologic emergency requiring prompt empiric antibiotics.
2
Risk stratify the patient using clinical criteria (e.g., MASCC or CISNE score) to determine the risk of serious complications.
The patient is classified as low-risk.
She has a solid tumor, is hemodynamically stable, lacks medical comorbidities, has no focal site of infection, tolerates oral intake, and has reliable social support.
3
Determine the appropriate care setting and empiric antibiotic regimen for a low-risk patient.
Discharge home with an oral fluoroquinolone (e.g., ciprofloxacin) plus amoxicillin-clavulanate.
Low-risk patients do not require hospitalization and can be safely managed as outpatients with oral antibiotics that provide broad-spectrum coverage, specifically including Pseudomonas aeruginosa.

Anahtar Kavram

Patients with low-risk febrile neutropenia (solid tumor, hemodynamically stable, no comorbidities, tolerating PO, good social support) should be discharged home with empiric oral antibiotics (e.g., a fluoroquinolone plus amoxicillin-clavulanate) rather than being admitted for intravenous therapy.
Soru 59Soru →

A 58-year-old man is evaluated in the hospital for a 5-day history of fever, nonproductive cough, and right-sided pleuritic chest pain. He underwent a deceased-donor renal transplantation eight months ago and is maintained on a daily immunosuppressive regimen of tacrolimus, mycophenolate mofetil, and low-dose prednisone. Vital signs are temperature 38.6∘C38.6^\circ\text{C} (101.5∘F101.5^\circ\text{F}), pulse 108/min108/\text{min}, respirations 20/min20/\text{min}, and blood pressure 138/82 mm Hg138/82\text{ mm Hg}. Chest computed tomography reveals a dense right upper lobe nodule with a surrounding halo of ground-glass attenuation. Serum galactomannan assay is strongly positive, and bronchoscopy with bronchoalveolar lavage confirms the diagnosis of invasive pulmonary aspergillosis. The medical team decides to initiate the standard first-line targeted intravenous antifungal therapy for this condition. Which of the following concurrent pharmacologic interventions is most appropriate for this patient?

Cevabı ve açıklamayı göster

Cevap: Decrease the current dosage of tacrolimus

Cevap

Decrease the current dosage of tacrolimus
This patient has a confirmed diagnosis of invasive pulmonary aspergillosis (IPA), indicated by the halo sign on CT and positive galactomannan. The standard-of-care targeted pharmacologic intervention is voriconazole. Voriconazole is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) isoenzyme. Tacrolimus, a calcineurin inhibitor crucial for preventing renal allograft rejection, has a narrow therapeutic index and is heavily metabolized by CYP3A4 in the liver and intestines. Concurrent initiation of voriconazole will dramatically reduce tacrolimus clearance, leading to toxic serum trough levels. This toxicity typically manifests as severe acute kidney injury (which is especially dangerous in a renal transplant recipient), hypertension, and neurologic complications such as seizures or posterior reversible encephalopathy syndrome (PRES). To safely manage this patient, the clinician must preemptively decrease the dosage of tacrolimus (often by 30% to 50%) when starting voriconazole and rigorously monitor serum trough levels.

Adım Adım Çözüm

1
Identify the primary diagnosis and the standard-of-care medication required.
The patient has invasive pulmonary aspergillosis (IPA). The first-line targeted pharmacologic therapy is intravenous voriconazole.
Establishing the specific antimicrobial required is necessary to evaluate its impact on the patient's complex baseline medication regimen.
2
Analyze the pharmacokinetic profile of the intended treatment against the patient's active medication list.
Voriconazole is a strong inhibitor of the hepatic cytochrome P450 3A4 (CYP3A4) enzyme system. The patient is taking tacrolimus, which is extensively metabolized by CYP3A4.
Identifying drug-drug interactions is critical in transplant patients to prevent organ rejection or drug toxicity.
3
Determine the necessary dosage adjustment based on the interaction.
Because voriconazole will inhibit the clearance of tacrolimus, the serum concentration of tacrolimus will rise significantly. The tacrolimus dose must be preemptively decreased (often by 1/3 to 1/2) and blood trough levels monitored closely.
Failure to reduce the dose will lead to acute calcineurin-inhibitor toxicity, manifesting as acute kidney injury, tremor, or seizures.

Anahtar Kavram

Initiation of voriconazole (a strong CYP3A4 inhibitor) for invasive aspergillosis requires a preemptive dose reduction of calcineurin inhibitors (like tacrolimus or cyclosporine) to prevent life-threatening drug toxicity.
Tahmini Süre:1m 30s
Soru 60Soru →

A 68-year-old man is preparing for discharge to a subacute rehabilitation facility following a prolonged hospitalization for acute decompensated heart failure and superimposed hospital-acquired pneumonia. His clinical course necessitated numerous changes to his baseline diuretic, antihypertensive, and diabetic regimens. The discharging physician is executing the formal medication reconciliation process to ensure safe continuity of care and prevent adverse drug events during this care transition. Arrange the following fundamental steps of the standardized medication reconciliation process in the correct chronological sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence for medication reconciliation is: 1) Acquire pre-admission history, 2) Review inpatient medications, 3) Cross-reference lists for discrepancies, 4) Resolve discrepancies clinically, and 5) Transmit the finalized regimen.
The Institute for Healthcare Improvement (IHI) and The Joint Commission mandate a standardized 5-step medication reconciliation process during transitions of care. The chronological process must strictly begin with obtaining the Best Possible Medication History (pre-admission list), followed by reviewing the current hospital medications. These two independent lists are then systematically cross-referenced to identify discrepancies (e.g., missing chronic medications, unintended duplications). The physician then uses clinical judgment to resolve these discrepancies and create a definitive discharge list. Finally, this accurate, finalized list must be formally communicated to the receiving facility (or primary care provider) and the patient to ensure safe continuity of care.

Adım Adım Çözüm

1
Establish the patient's baseline regimen.
Creation of the Best Possible Medication History (pre-admission list).
It is impossible to identify medication omissions or unintended changes without knowing the exact starting point.
2
Identify all current acute therapies.
Compilation of the inpatient medication list.
This is necessary to understand what therapies were added, discontinued, or modified during the hospitalization.
3
Compare the baseline list with the acute therapy list.
Identification of any medication discrepancies.
This systematic comparison highlights unintended omissions of chronic medications or inappropriate continuations of acute-only treatments.
4
Apply clinical decision-making to the discrepancies.
Formulation of the finalized discharge medication regimen.
Ensures that the final list is medically appropriate for the patient's current post-acute stability and ongoing chronic needs.
5
Communicate the final regimen to the next care setting.
Safe transition of care and implementation of the correct treatments.
Prevents administration errors, adverse drug events, and readmissions caused by communication failures at the receiving facility.

Anahtar Kavram

Medication reconciliation during care transitions is a structured, standardized five-step process designed to prevent adverse drug events by systematically identifying and resolving medication discrepancies before patient handoffs.
ÖncekiSayfa 3 / 104Sonraki
Patient Management Alıştırma Soruları — USMLE Step 3 — Sayfa 3 | Examkin